DiGeorge Syndrome Critical Region Gene 8 (DGCR8) (N-Term) Peptide
DGCR8
适用: 人
宿主: 合成
BP, WB, IHC
产品编号 ABIN975746
发货至:
中国
Contact our Customer Service for availability and price in your country.
Contact Info
Our Local Distributor
中国
北京 101111
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
Quick Overview for DiGeorge Syndrome Critical Region Gene 8 (DGCR8) (N-Term) Peptide (ABIN975746)
抗原
DGCR8
(DiGeorge Syndrome Critical Region Gene 8 (DGCR8))
宿主
人
资源
合成
应用范围
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
-
-
蛋白结构域
- N-Term
-
产品特性
- This is a synthetic peptide designed for use in combination with anti-DGCR8 antibody (Catalog #: ARP40984_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
纯化方法
- Purified
-
-
-
-
应用备注
- Each Investigator should determine their own optimal working dilution for specific applications.
-
限制
- 仅限研究用
-
-
-
状态
- Lyophilized
-
溶解方式
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
浓度
- 1 mg/mL
-
缓冲液
- Final peptide concentration is 1 mg/mL in PBS.
-
注意事项
- Avoid repeated freeze-thaw cycles.
-
储存条件
- -20 °C
-
储存方法
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- DGCR8 (DiGeorge Syndrome Critical Region Gene 8 (DGCR8))
-
背景
-
DGCR8 contains 2 DRBM (double-stranded RNA-binding) domains and 1 WW domain. It may play a part in the etiology of the velocardiofacial/DiGeorge syndrome (VCFS/DGS), a developmental disorder characterized by structural and functional palate anomalies, conotruncal cardiac malformations, immunodeficiency, hypocalcemia, and typical facial anomalies.
Alias Symbols: C22orf12, DGCRK6, Gy1, pasha
Protein Interaction Partner: RNASEN,RNASEN,RNASEN
Protein Size: 773 -
分子量
- 85 kDa
-
基因ID
- 54487
-
NCBI登录号
- NM_022720, NP_073557
-
UniProt
- Q8WYQ5
抗原
-
You are here:
